Lindsey Herrel, MD
Urology · Ann Arbor, MINPI 1700029154
Payments from drug & device makers
What this record shows
This record is dominated by grants: $14,684 of the $14,811 with a category attached, or 99.1%. Pfizer accounts for 99.1% of it on its own, with 3 other manufacturers making up the rest. 2024 is the largest year on record at $14,684, more than ten times the $64 reported in 2019.
Across 4 payments — averaging $3702.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$15K
- Boston Scientific$64
- AstraZeneca$45
- Taiho Oncology, Inc.$18
Across 2 payments — averaging $66,078 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$132K
What the payments were for
- Grants$14,68499%
- Travel & lodging$620%
- Food & beverage$640%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 1 | $14,684 |
| Boston Scientific | 1 | $64 |
| AstraZeneca | 1 | $45 |
| Taiho Oncology, Inc. | 1 | $18 |
How this compares
$14,811 in reported general payments places this provider in the 85th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 15 | $15,113 |
| Tamsulosin Hcl | 43 | $888 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $456 |
| Finasteride | 21 | $235 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 18 | $154 |
| Ciprofloxacin Hcl | 15 | $70 |
| Ondansetron Hcl | 15 | $44 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other urology in Ann Arbor
- William RobertsAnn Arbor$973K
- Khurshid GhaniAnn Arbor$413K
- Casey DauwAnn Arbor$188K
- Bahaa MalaebAnn Arbor$98K
- James ClemensAnn Arbor$63K
- Todd MorganAnn Arbor$34K
- Stephanie KielbAnn Arbor$26K
- Yooni BlairAnn Arbor$22K
- John StoffelAnn Arbor$17K
- Ashok ReddySterling Heights$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.